Chongqing Maichuan Medical Technology Co., Ltd.

Main purpose: Using the Mycophenol Sodium Enteric-coated Tablets (specification: 0.18 g based on mycophenolic acid ((C17H20O6)) of Chongqing Maichuan Pharmaceutical Technology Co., Ltd. as the test preparation and the Mycophenol Sodium Enteric-coated Tablets (trade name: Myfortic®/Mifu®, specification: 180 mg) of Novartis Pharma GmbH as the reference preparation, the bioequivalence of the two preparations in healthy humans was investigated according to the relevant provisions of the bioequivalence test. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.